Related Experiment Video
Updated: Jan 31, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
AdipoRon prevents l-thyroxine or isoproterenol-induced cardiac hypertrophy through regulating the AMPK-related
Xinlei Hu1, Qiong Ou-Yang1, Lanlan Wang1
1Jiangsu Key Lab of Drug Screening and Jiangsu Key Lab of Metabolic Disease and Drug Discovery, China Pharmaceutical University, Nanjing, China.
Insights
AdipoRon treatment reversed cardiac hypertrophy in rats, reducing heart weight and BNP levels. This effect is partly mediated by activating the AMPK-related pathway, suggesting AdipoRon
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Pharmacology
Background:
- Cardiac hypertrophy is a significant risk factor for heart failure.
- Understanding molecular pathways involved in cardiac hypertrophy is crucial for developing therapeutic strategies.
- AdipoRon's potential role in mitigating cardiac hypertrophy requires investigation.
Purpose of the Study:
- To investigate whether AdipoRon attenuates isoprenaline (ISO) or l-thyroxine-induced cardiac hypertrophy in Sprague-Dawley rats.
- To determine if the anti-hypertrophy effect of AdipoRon is mediated by the AMPK-related pathway.
Main Methods:
- Cardiac hypertrophy was induced in Sprague-Dawley rats using ISO or l-thyroxine.
- AdipoRon was co-administered to the treatment group.
- Measurements included heart and left ventricular weight, serum BNP levels, cardiac hypertrophy markers (ANP, BNP), and protein/mRNA expression of key signaling molecules (PGC-1α, ERRα, pAMPK/AMPK) via RT-PCR and Western blot.
Main Results:
- AdipoRon significantly reversed the increase in heart weight/body weight ratio, left ventricular/body weight ratio, serum BNP, and ANP/BNP mRNA levels induced by ISO or l-thyroxine.
- ISO or l-thyroxine reduced ERRα, PGC-1α mRNA/protein levels, and pAMPK/AMPK protein levels.
- AdipoRon treatment restored the levels of pAMPK/AMPK, ERRα, and PGC-1α, indicating activation of the AMPK-related pathway.
Conclusions:
- AdipoRon effectively attenuates cardiac hypertrophy induced by ISO or l-thyroxine in rats.
- The anti-hypertrophic effects of AdipoRon are partly mediated through the activation of the AMPK-related pathway.
- AdipoRon demonstrates potential as a therapeutic agent for preventing cardiac hypertrophy.
Abstract:
Cardiac hypertrophy is a risk factor which can intrigue heart failure. In the present study, we explored whether AdipoRon attenuates isoprenaline (ISO) or l-thyroxine-induced cardiac hypertrophy in Sprague-Dawley (SD) rats and whether the anti-hypertrophy effect is mediated by AMPK-related pathway. Here, cardiac hypertrophy was induced by injection of l-thyroxine or ISO in SD rats. In the treatment group, AdipoRon was co-administered. We examined the effects of AdipoRon on cardiac hypertrophy and hypertrophy signaling pathway. The weight of SD rats was recorded every day. Rats were killed for collection of blood and heart under anesthesia. The left heart weight and heart weight were weighed. Paraffin-embedded heart tissue regions (4 μm) were stained with hematoxylin and eosin or Masson to detect left heart hypertrophy and myocardial fibrosis. The serum BNP levels were determined by using an enzyme-linked immunosorbent assay. The mRNA levels of ANP, BNP, PGC-1α, and ERRα were evaluated by real-time PCR analysis. The protein expression levels of PGC-1α, ERRα, and pAMPK/AMPK were determined by western blot analysis. The results showed that AdipoRon significantly reversed heart weight (HW)/body weight (BW) ratio, left ventricular (LV)/BW ratio, serum BNP level and the mRNA level of ANP and BNP induced by ISO or l-thyroxine. ISO or l-thyroxine reduced both the mRNA level and protein level of ERRα and PGC-1α, and also reduced the protein level of pAMPK/AMPK. However, AdipoRon reversed ISO or l-thyroxine-induced changes of pAMPK/AMPK, ERRα, and PGC-1α. Our data indicated that the effects of AdipoRon are mediated partly by activating AMPK-related pathway, and AdipoRon plays a potential role in the prevention of cardiac hypertrophy.
More Related Videos
09:24O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
10:18Ascending Aortic Constriction in Rats for Creation of Pressure Overload Cardiac Hypertrophy Model
Published on: June 29, 2014
Related Concept Videos
GTPases and their Regulation
Large G-proteins,...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Epigenetic Regulation
Cancer Prevention
Some...
Master Transcription Regulators
Negative Regulator Molecules